MRK will spinoff women’s health, off-patent brands, and biosimilars into new (as yet unnamed) company: https://finance.yahoo.com/news/merck-focus-key-growth-pillars-114500519.html The spinoff is expected to have ~$6.5B of annual sales (~15% of existing MRK), of which 75% will be ex-US. The spinoff is expected to occur in 1H21.